339 related articles for article (PubMed ID: 23637312)
1. Mesenchymal stromal cells in transplantation rejection and tolerance.
English K; Wood KJ
Cold Spring Harb Perspect Med; 2013 May; 3(5):a015560. PubMed ID: 23637312
[TBL] [Abstract][Full Text] [Related]
2. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?
Griffin MD; Ryan AE; Alagesan S; Lohan P; Treacy O; Ritter T
Immunol Cell Biol; 2013 Jan; 91(1):40-51. PubMed ID: 23207278
[TBL] [Abstract][Full Text] [Related]
3. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.
Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T
Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237
[TBL] [Abstract][Full Text] [Related]
4. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
Johnstone BH; Messner F; Brandacher G; Woods EJ
Front Immunol; 2021; 12():622604. PubMed ID: 33732244
[TBL] [Abstract][Full Text] [Related]
5. Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation.
Casiraghi F; Todeschini M; Azzollini N; Cravedi P; Cassis P; Solini S; Fiori S; Rota C; Karachi A; Carrara C; Noris M; Perico N; Remuzzi G
Transplantation; 2019 Jun; 103(6):1121-1130. PubMed ID: 30801518
[TBL] [Abstract][Full Text] [Related]
6. The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation.
Reinders ME; Rabelink TJ; de Fijter JW
Curr Opin Organ Transplant; 2013 Feb; 18(1):44-50. PubMed ID: 23254697
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cardiac allograft rejection in mice using interleukin-35-modified mesenchymal stem cells.
Wang W; Zhao N; Li B; Gao H; Yan Y; Guo H
Scand J Immunol; 2019 Apr; 89(4):e12750. PubMed ID: 30664805
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stromal Cells for Transplant Tolerance.
Podestà MA; Remuzzi G; Casiraghi F
Front Immunol; 2019; 10():1287. PubMed ID: 31231393
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells can affect solid organ allograft survival.
Popp FC; Eggenhofer E; Renner P; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
Transplantation; 2009 May; 87(9 Suppl):S57-62. PubMed ID: 19424009
[TBL] [Abstract][Full Text] [Related]
10. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting.
Nauta AJ; Westerhuis G; Kruisselbrink AB; Lurvink EG; Willemze R; Fibbe WE
Blood; 2006 Sep; 108(6):2114-20. PubMed ID: 16690970
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stromal Cells in Solid Organ Transplantation.
Vandermeulen M; Erpicum P; Weekers L; Briquet A; Lechanteur C; Detry O; Beguin Y; Jouret F
Transplantation; 2020 May; 104(5):923-936. PubMed ID: 31929427
[TBL] [Abstract][Full Text] [Related]
12. Netrin-1 prolongs skin graft survival by inducing the transformation of mesenchymal stem cells from pro-rejection to immune-tolerant phenotype.
Liu LP; Chen W; Fan Y; Qi BY; Wang Z; Shi BY
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8741-8750. PubMed ID: 31696460
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells and their immunosuppressive role in transplantation tolerance.
Contreras-Kallens P; Terraza C; Oyarce K; Gajardo T; Campos-Mora M; Barroilhet MT; Álvarez C; Fuentes R; Figueroa F; Khoury M; Pino-Lagos K
Ann N Y Acad Sci; 2018 Apr; 1417(1):35-56. PubMed ID: 28700815
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials.
Pileggi A; Xu X; Tan J; Ricordi C
Curr Opin Organ Transplant; 2013 Dec; 18(6):672-81. PubMed ID: 24220050
[TBL] [Abstract][Full Text] [Related]
15. Dose- and Time-Dependent Effects of Human Mesenchymal Stromal Cell Infusion on Cardiac Allograft Rejection in Mice.
Wang F; Chen X; Li J; Wang D; Huang H; Li X; Bi Z; Peng Y; Zhang X; Li G; Wang J; Wang C; Fu Q; Liu L
Stem Cells Dev; 2021 Feb; 30(4):203-213. PubMed ID: 33371825
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell Implants.
Hoornaert CJ; Luyckx E; Reekmans K; Dhainaut M; Guglielmetti C; Le Blon D; Dooley D; Fransen E; Daans J; Verbeeck L; Quarta A; De Vocht N; Lemmens E; Goossens H; Van der Linden A; Roobrouck VD; Verfaillie C; Hendrix S; Moser M; Berneman ZN; Ponsaerts P
Stem Cells; 2016 Jul; 34(7):1971-84. PubMed ID: 26992046
[TBL] [Abstract][Full Text] [Related]
17. Kidney-derived mesenchymal stromal cells modulate dendritic cell function to suppress alloimmune responses and delay allograft rejection.
Huang Y; Chen P; Zhang CB; Ko GJ; Ruiz M; Fiorina P; Hussain MA; Wasowska BA; Rabb H; Womer KL
Transplantation; 2010 Dec; 90(12):1307-11. PubMed ID: 21048532
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic Mesenchymal Stromal Cells Transplanted Onto the Heart Surface Achieve Therapeutic Myocardial Repair Despite Immunologic Responses in Rats.
Tano N; Kaneko M; Ichihara Y; Ikebe C; Coppen SR; Shiraishi M; Shintani Y; Yashiro K; Warrens A; Suzuki K
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26896478
[TBL] [Abstract][Full Text] [Related]
19. Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival.
Koch M; Lehnhardt A; Hu X; Brunswig-Spickenheier B; Stolk M; Bröcker V; Noriega M; Seifert M; Lange C
Transpl Immunol; 2013 Dec; 29(1-4):43-50. PubMed ID: 23994720
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory properties and therapeutic application of mesenchymal stem cells.
Shi M; Liu ZW; Wang FS
Clin Exp Immunol; 2011 Apr; 164(1):1-8. PubMed ID: 21352202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
